Generation of induced pluripotent stem cells from three individuals with Huntington‘s disease

Generation of induced pluripotent stem cells from three individuals with Huntington‘s disease

Huntington’s disease (HD) is a neurodegenerative disorder caused by abnormal glutamine (Q) expansion in the huntingtin protein due to elongated CAG repeats in the gene HTT. We used non-integrative episomal plasmids to generate induced pluripotent stem cells (iPSCs) from three individuals affected by...

Full description

Bibliographic Details
Main Authors:	Duncan C. Miller, Pawel Lisowski, Selene Lickfett, Barbara Mlody, Miriam Bünning, Carolin Genehr, Claas Ulrich, Erich E. Wanker, Sebastian Diecke, Josef Priller, Alessandro Prigione
Format:	Article
Language:	English
Published:	Elsevier 2022-12-01
Series:	Stem Cell Research
Online Access:	http://www.sciencedirect.com/science/article/pii/S1873506122003257

Similar Items

Generation of an induced pluripotent stem cell line from a Huntington’s disease patient with a long HTT-PolyQ sequence
by: Duncan C. Miller, et al.
Published: (2023-04-01)

Generation of four iPSC lines from four patients with Leigh syndrome carrying homoplasmic mutations m.8993T > G or m.8993T > C in the mitochondrial gene MT-ATP6
by: Carmen Lorenz, et al.
Published: (2022-05-01)

High-content analysis of neuronal morphology in human iPSC-derived neurons
by: Selene Lickfett, et al.
Published: (2022-09-01)

RNA Sequencing of Human Peripheral Blood Cells Indicates Upregulation of Immune-Related Genes in Huntington's Disease
by: Miguel A. Andrade-Navarro, et al.
Published: (2020-11-01)

Small, Seeding-Competent Huntingtin Fibrils Are Prominent Aggregate Species in Brains of zQ175 Huntington’s Disease Knock-in Mice
by: Franziska Schindler, et al.
Published: (2021-06-01)

Ku70 alleviates neurodegeneration in Drosophila models of Huntington's disease.
by: Takuya Tamura, et al.
Published: (2011-01-01)

HIGH-THROUGHPUT KNOCKDOWN SCREENING FOR MODIFIERS OF NEURONAL MORPHOLOGY IN LEIGH SYNDROME PATIENT-DERIVED NEURONS
by: Selene Lickfett, et al.
Published: (2023-10-01)

Generation of two mother–child pairs of iPSCs from maternally inherited Leigh syndrome patients with m.8993 T > G and m.9176 T > G MT-ATP6 mutations
by: Marie-Thérèse Henke, et al.
Published: (2023-03-01)

A platform for studies of Huntington’s disease on the basis of induced pluripotent stem cells
by: E. D. Nekrasov, et al.
Published: (2017-02-01)

Analysis of the Circadian Regulation of Cancer Hallmarks by a Cross-Platform Study of Colorectal Cancer Time-Series Data Reveals an Association with Genes Involved in Huntington’s Disease
by: Müge Yalçin, et al.
Published: (2020-04-01)

Structural neuroimaging differentiates vulnerability from disease manifestation in colombian families with Huntington's disease
by: Maria del C. Valdés Hernández, et al.
Published: (2019-08-01)

Symptomatic treatment options for Huntington’s disease (guidelines of the German Neurological Society)
by: Carsten Saft, et al.
Published: (2023-11-01)

Zebrafish as a model organism for neurodegenerative disease
by: Kelda Chia, et al.
Published: (2022-10-01)

Lentiviral delivery of human erythropoietin attenuates hippocampal atrophy and improves cognition in the R6/2 mouse model of Huntington's disease
by: Simone Rolfes, et al.
Published: (2020-10-01)

Generation of two human induced pluripotent stem cell lines derived from myoblasts (MDCi014-A) and from peripheral blood mononuclear cells (MDCi014-B) from the same donor
by: Eric Metzler, et al.
Published: (2020-10-01)

High-content screening of mitochondrial polarization in neural cells derived from human pluripotent stem cells
by: Annika Zink, et al.
Published: (2022-09-01)

Chromosomal Instability and Molecular Defects in Induced Pluripotent Stem Cells from Nijmegen Breakage Syndrome Patients
by: Tomer Halevy, et al.
Published: (2016-08-01)

Metformin reverses early cortical network dysfunction and behavior changes in Huntington’s disease
by: Isabelle Arnoux, et al.
Published: (2018-09-01)

Astrocytes generated from patient induced pluripotent stem cells recapitulate features of Huntington’s disease patient cells
by: Juopperi Tarja A, et al.
Published: (2012-05-01)

The ubiquitin ligase UBR5 suppresses proteostasis collapse in pluripotent stem cells from Huntington’s disease patients
by: Seda Koyuncu, et al.
Published: (2018-07-01)

Genomic Instability Associated with p53 Knockdown in the Generation of Huntington's Disease Human Induced Pluripotent Stem Cells.
by: Andrew M Tidball, et al.
Published: (2016-01-01)

Chromatin accessibility and transcription dynamics during in vitro astrocyte differentiation of Huntington’s Disease Monkey pluripotent stem cells
by: Alexandra V. Goodnight, et al.
Published: (2019-11-01)

Reversal of Cellular Phenotypes in Neural Cells Derived from Huntington’s Disease Monkey-Induced Pluripotent Stem Cells
by: Richard L. Carter, et al.
Published: (2014-10-01)

Generation of 20 human induced pluripotent stem cell lines from patients with focal segmental glomerulosclerosis (FSGS)
by: Janine Cernoch, et al.
Published: (2021-07-01)

Peripheral Biomarkers in Manifest and Premanifest Huntington’s Disease
by: Emanuele Morena, et al.
Published: (2023-03-01)

The difficulty to model Huntington’s disease in vitro using striatal medium spiny neurons differentiated from human induced pluripotent stem cells
by: Kim Le Cann, et al.
Published: (2021-03-01)

Mitochondrial and Redox Modifications in Huntington Disease Induced Pluripotent Stem Cells Rescued by CRISPR/Cas9 CAGs Targeting
by: Carla Lopes, et al.
Published: (2020-09-01)

Generation of induced pluripotent stem cell line, CSSi004-A (2962), from a patient diagnosed with Huntington's disease at the presymptomatic stage
by: Eris Bidollari, et al.
Published: (2018-04-01)

New production patterns and the future of manufacturing relocation trend in the 4.0 era: The perspective of consumers
by: Michał Młody
Published: (2018-09-01)

Backshoring in Light of the Concepts of Divestment and De-internationalization: Similarities and Differences
by: Michał Młody
Published: (2016-09-01)

The centrosomal protein 83 (CEP83) regulates human pluripotent stem cell differentiation toward the kidney lineage
by: Fatma Mansour, et al.
Published: (2022-10-01)

Huntington’s disease complicated by traumatic subarachnoid bleeding and subdural hematoma
by: J. Josef Finsterer, et al.
Published: (2021-09-01)

Generation of three age and gender matched pairs of human induced pluripotent stem cells derived from myoblasts (MDCi011-A, MDCi012-A, MDCi013-A) and from peripheral blood mononuclear cells (MDCi011-B, MDCi012-B, MDCi013-B) from the same donor
by: Eric Metzler, et al.
Published: (2020-10-01)

Transplantation of neuronal precursors derived from induced pluripotent stem cells into the striatum of rats with the toxin-induced model of Huntington’s disease
by: Alla V. Stavrovskaya, et al.
Published: (2017-02-01)

Induced pluripotent stem cells from Huntington’s disease patients: a promising approach to define and correct disease-related alterations
by: Azra Fatima, et al.
Published: (2019-01-01)

Huntington's "Gap"
by: Ricardo Lagorio
Published: (2017-11-01)

Special Issue “Microglia Heterogeneity and Its Relevance for Translational Research”
by: Alessandro Michelucci, et al.
Published: (2021-11-01)

Induced pluripotent stem cells and cerebral organoids from the critically endangered Sumatran rhinoceros
by: Vera Zywitza, et al.
Published: (2022-11-01)

Generation of the induced pluripotent stem cell line CSSi006-A (3681) from a patient affected by advanced-stage Juvenile Onset Huntington's Disease
by: Giovannina Rotundo, et al.
Published: (2018-05-01)

Reversal of Phenotypic Abnormalities by CRISPR/Cas9-Mediated Gene Correction in Huntington Disease Patient-Derived Induced Pluripotent Stem Cells
by: Augustine, George James, et al.
Published: (2017)